Healthy potentially undervalued

Results

2405

Companies which are potentially undervalued and in an acceptable financial position.

2405 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	IMG	CA$24.76	10.1%	124.5%	CA$14.4b	CA$32.17	8.8	7.6%	n/a	Materials
	LOUP	€112.40	-1.6%	22.8%	€3.9b	€138.00	12.1	4.2%	2.0%	Food, Beverage & Tobacco
	KOF	€24.95	-0.6%	-21.2%	€489.7m	€36.76	9.0	1.2%	8.8%	Consumer Durables
	FLOC	US$22.76	8.6%	40.1%	US$2.1b	US$31.11	20.1	29.1%	1.6%	Energy
	BZ	US$15.42	-4.2%	-27.7%	US$7.2b	US$20.83	13.8	6.4%	1.1%	Commercial Services
	ACX	CA$6.57	6.8%	35.7%	CA$253.1m	CA$10.25	9.9	9.4%	0%	Energy
	DEME	€166.20	0.6%	27.8%	€4.2b	€221.75	12.1	4.7%	2.7%	Capital Goods
	HITI	CA$3.24	0.9%	-7.7%	CA$285.6m	CA$7.30	0.4	63.2%	n/a	Pharmaceuticals & Biotech
	LKQ	US$25.20	3.0%	-20.2%	US$6.3b	US$32.50	13.7	16.5%	4.8%	Retail
	TCL.A	CA$5.29	0.6%	-72.8%	CA$447.9m	CA$7.17	2.9	-32.0%	3.8%	Materials
	SGRY	US$15.19	1.8%	-32.5%	US$2.0b	US$18.73	0.6	125.8%	n/a	Healthcare
	LKNC.Y	US$35.06	0.6%	-8.2%	US$10.9b	US$48.21	20.2	23.3%	n/a	Consumer Services
	TKO	€16.92	0%	-14.9%	€2.9b	€21.45	12.5	12.9%	4.7%	Diversified Financials
	CDA	€20.65	-1.7%	-12.1%	€1.0b	€26.20	8.9	3.1%	5.3%	Consumer Services
	TRLV	US$9.60	6.7%	18.4%	US$1.8b	US$18.18	1.6	124.9%	n/a	Pharmaceuticals & Biotech
	74SW	€38.00	0%	-0.3%	€1.1b	€46.14	17.7	14.3%	0%	Software
	SSRM	CA$44.35	10.0%	99.4%	CA$9.2b	CA$56.91	11.5	17.1%	0.4%	Materials
	EN	€47.58	-3.3%	21.9%	€18.4b	€60.00	14.7	9.3%	4.4%	Capital Goods
	HURN	US$155.31	3.5%	16.9%	US$2.4b	US$190.75	21.4	24.1%	n/a	Commercial Services
	AR	US$36.82	5.5%	13.9%	US$11.5b	US$49.35	10.4	5.6%	n/a	Energy
	OSB	UK£5.00	-1.5%	-11.1%	UK£1.7b	UK£6.63	6.2	6.8%	7.1%	Diversified Financials
	TESB	€20.85	-4.4%	-20.7%	€1.2b	€25.50	0.4	74.6%	3.6%	Materials
	BAG	UK£5.99	-1.8%	-12.4%	UK£664.7m	UK£7.80	14.1	8.8%	3.1%	Food, Beverage & Tobacco
	BLBD	US$64.67	-2.0%	14.6%	US$2.0b	US$89.13	7.3	-8.1%	n/a	Capital Goods

Page 1 of 67